All Type of News
The amount of pharmaceutical production last year was KRW 16.38 trillion… it shows a 6.07% annual increase rate
It is observed that the amount of domestic pharmaceutical production in the last year reached KRW 16.38 trillion.
The Ministry of Food and Drug Safety published ‘Industrial Trend Statistics of Foods and Drugs’, andma...
Noticeable phenomena of aggravated profitability with listed pharmaceutical companies
It is expected that profitability of listed pharmaceutical companies will keep being aggravated.
Sales of the third quarter have recorded the average as the last year, but business profits and net profits do not seem...
Exemption of anticancer drugs from targets of damage relief program for drug side effects
Anticancer drugs and immune disorder treatments have been exempted from targets of damage relief for drugside effects.
The Ministry of Food and Drug Safety (MFDS) made a public announcement on the 28th that several p...
Continuing decreases in stocks of pharmaceutical companies on the fourth quarter… market capital has dropped by 1.6%
Stocks of pharmaceutical companies in KOSPI have continued to decrease since the beginning of the fourth quarter.
According to the Daily Pharm’s analysis of market capitalization of 34 KOSPI pharmaceutical companies ...
Pharmaceutical companies’ co-marketing generates either ‘Jackpots’ or ‘Bankruptcies’
There is nothing new about co-marketing and co-promotion among pharmaceutical companies to be succeeded in certain product anymore. However, these types of cooperation do not guarantee success. The following are notic...
“Attractivepharmaceutical and biopharmaceutical companies that will be newly listed on December”
As 6 new pharmaceutical companies have waited to be newly listed on December, the industry analyzed that all of the companies are attractive for stock investors.
Al-eum Lee, an analyst of Hana Daetoo Securities Co., ...
The Celltrion’s biosimilar product ‘Remsima’acquired the drug price registration in JapanThe Celltrion’s biosimilar product ‘Remsima’has been registered in Japan.
Remsima has been included in the Japanese ‘Reported Items, Sinkit Product List’ (expected to be regist...
|
It has been 5 years since the launch of ‘Herceptin’… a targeted agent for stomach cancer will come outIt is expected that a new targeted agent will be launched since the launch of ‘Herceptin’ 5 years ago.
According to the industry concerned on the 28th, Lilly Korea is following...
|
The positive forecast of ‘Sivextro’ expecting sales worth of $900 billion before 2019‘Sivextro (generic name: tedizolid)’, a super antibiotic developed by Dong-A ST, is positively forecasted to make the highest sales, including sales in the U.S. and Europe, wort...
|
A new global hypertension complex ‘Amosartan’ acquired a patent in JapanThe Hanmi Pharmaceutical’s (executive director Kwan-soon Lee)new global hypertension complex ‘Amosartan’has acquired a composite patent (application number: JP2011547746) in Jap...
|
